Our study demonstrates that blocking p53 activity also blocks CDK7-inhibition–induced GSDME overexpression (Figures 5A,C) and partially restores breast cancer cell proliferation and colony formation capacity from the suppressive effect of CDK7 inhibition. This evidence concerns the gene TP53 and breast carcinoma.